As of 3:59pm ET
| -0.1641 / -4.90%|
The 4 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 22.64, with a high estimate of 25.04 and a low estimate of 18.00. The median estimate represents a +610.63% increase from the last price of 3.19.
The current consensus among 2 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.